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A
strong association between obstructive sleep apnea
(OSA) and atrial ﬁbrillation has been consistently
observed in both epidemiological and clinical cohorts, and
multiple studies demonstrate that OSA is associated with an
increased risk of atrial ﬁbrillation recurrence following chem-
ical or electrical cardioversion or pulmonary vein isolation by
catheter ablation. The study by Neilan et al, in this issue of
the Journal of the American Heart Association,
1 adds to a
growing number of studies demonstrating that not only is OSA
associated with an increased risk of atrial ﬁbrillation recur-
rence following pulmonary vein isolation, but also that
treatment with continuous positive airway pressure (CPAP)
appears to eliminate this excess risk.
2–4 These studies share
certain important methodological limitations. The presence of
OSA was systematically assessed in only one study
4; in the
others it was based on a prior diagnosis of OSA at the time of
pulmonary vein isolation. The “non-OSA” groups therefore
almost certainly include many patients with OSA, likely
resulting in underestimation of the association of OSA with
atrial ﬁbrillation recurrence compared with non-OSA controls,
while overestimating the beneﬁts of OSA treatment. Adher-
ence to CPAP was generally based on self-report, and thus
likely overestimated, which would lead to an underestimate of
the beneﬁts of CPAP. Most importantly, none of these studies
was a randomized clinical trial. As CPAP non-adherence may
be a marker of poorer adherence to other recommended
medical therapies that could affect the recurrence of atrial
ﬁbrillation, this could lead to an overestimate of the beneﬁts
of CPAP therapy. Notwithstanding these limitations, the
consistency of the observations in these clinical cohorts
contributes to a body of evidence that strongly implicates
OSA as a cause, and not merely a correlate, of atrial
ﬁbrillation.
Obstructive sleep apnea is characterized by repeated
episodes of partial or complete pharyngeal collapse during
sleep, resulting in large negative swings in intrathoracic
pressure during attempts to ventilate through the obstructed
airway (Mueller maneuver), intermittent hypercapnic hypoxia,
and arousal at the termination of the obstructive events. The
negative intrathoracic pressure results in large changes in
transmural pressure and atrial volume, while both hypercapnic
hypoxia and arousal increase sympathetic nervous system
activation and result in large surges in blood pressure. These
consequences of OSA are likely responsible for well-docu-
mented cardiac structural changes, including increases in left
ventricular mass index
5 and left atrial volume.
6 In a sample of
patients with severe OSA, normal left ventricular ejection
fraction, and no history of atrial ﬁbrillation studied with
cardiac magnetic resonance imaging before and 6 and
12 months after initiation of CPAP, it was shown that CPAP
treatment was associated with a marked decrease in left
ventricular mass index and both left and right atrial volume
indices.
7 As left atrial diameter is a known predictor of
recurrence of atrial ﬁbrillation, cardiac structural changes are
plausibly responsible for the elevated rates of recurrence
observed in patients with OSA. Neilan and colleagues sought
to explore this possibility by determining whether treatment
of OSA leads to beneﬁcial cardiac remodeling in a population
with atrial ﬁbrillation, and whether such beneﬁcial remodeling
mediated a reduction in the risk of recurrent atrial ﬁbrillation
following pulmonary vein isolation.
1 In addressing this ques-
tion they take advantage of cardiac magnetic resonance
imaging performed as a routine component of the pre-ablation
evaluation, presenting the largest sample of OSA patients to
date evaluated with this state-of-the-art measure of cardiac
structure and function. Consistent with prior echocardio-
graphic studies, they ﬁnd that the strongest structural
correlates of OSA are higher left ventricular mass index and
larger left atrial diameter. Moreover, these differences are
accounted for almost entirely by CPAP-non-adherent patients,
while patients reporting CPAP use >4 hours per night have
The opinions expressed in this article are not necessarily those of the editors
or of the American Heart Association.
From the VA Boston Healthcare System, Brigham and Women’s Hospital, and
Harvard Medical School, Boston, MA.
Correspondence to: Daniel J. Gottlieb, MD, MPH, VA Boston Healthcare
System (111PI), 1400 VFW Parkway, West Roxbury, MA 02132. E-mail:
djgottlieb@partners.org
J Am Heart Assoc. 2014;3:e000654 doi: 10.1161/JAHA.113.000654.
ª 2014 The Authors. Published on behalf of the American Heart Association,
Inc., by Wiley Blackwell. This is an open access article under the terms of the
Creative Commons Attribution-NonCommercial License, which permits use,
distribution and reproduction in any medium, provided the original work is
properly cited and is not used for commercial purposes.
DOI: 10.1161/JAHA.113.000654 Journal of the American Heart Association 1
EDITORIALleft ventricular mass index and left atrial diameter that are
virtually identical to those in the “non-OSA” group. As CPAP
treatment had been initiated in advance of magnetic
resonance imaging, the authors conclude that treatment with
CPAP led to beneﬁcial cardiac remodeling. While the data are
consistent with this interpretation, the availability of cardiac
imaging at only a single time point markedly limits the
strength of inferences that can be drawn regarding structural
remodeling.
Unfortunately, the authors did not take full advantage of
the available data to address the important question they
pose: whether the lower incidence of recurrent atrial ﬁbrilla-
tion in treated OSA is a result of the posited beneﬁcial effect
of treatment on cardiac structure (and conversely, whether
cardiac structural abnormalities explain the increased risk of
recurrence in untreated OSA). No formal mediation analysis is
presented. The multivariable proportional hazards regression
that the authors present, however, suggests that structural
changes may not underlie the increased recurrence risk
in untreated OSA, at least so far as left atrial dimension
is concerned. In this model, although left atrial dimension is
signiﬁcantly associated with increased risk of recurrence, the
adjusted hazard ratio for recurrent atrial ﬁbrillation in
untreated OSA (compared with no OSA) is 2.8 (95%
conﬁdence interval, 2.0 to 3.9), similar to the crude difference
in recurrence between these groups. This is consistent with
the similar ﬁndings in studies of like design,
2,3 although as
cardiac imaging was not repeated following the baseline
evaluation, one could speculate that remodeling occurring
during the period of follow-up might have reduced the risk of
recurrence. (No inference can be made with regard to left
ventricular mass index, which was not included in this model.)
Given the high prevalence of OSA in patients with atrial
ﬁbrillation, and the apparent large effects of CPAP treatment
on rates of recurrence following pulmonary vein isolation, it
would not be difﬁcult to design an adequately powered
randomized clinical trial to conclusively determine whether
CPAP therapy in fact reduces the risk of late recurrence of
atrial ﬁbrillation, a ﬁnding that would have major implications
for clinical practice. By embedding a repeat measure of
cardiac structure at an appropriate interval after the initiation
of CPAP therapy, it would be possible to clarify the true effect
of OSA treatment on cardiac remodeling, and provide an
opportunity to formally test the extent to which such
remodeling mediates the observed reduction in risk of
recurrent atrial ﬁbrillation.
There is good reason to expect, however, that the
mechanisms whereby CPAP therapy protects against recur-
rent atrial ﬁbrillation are not operating through cardiac
structural remodeling. It has been shown that the risk of
paroxysmal atrial ﬁbrillation is markedly increased in the
immediate post-apnea period,
8 suggesting that acute effects
of the obstructed breathing events may be important triggers
for induction of atrial ﬁbrillation. This may reﬂect the effects
of acute gas exchange abnormalities, changes in autonomic
activity, or the mechanical effects of large intrathoracic
pressure swings. Hypoxemia following obstructed breathing
events is commonly cited as a potential mediator of atrial
ﬁbrillation in OSA, although more recently an important role
has been suggested for hypercapnia, which acutely reduces
vulnerability to atrial ﬁbrillation by increasing atrial effective
refractory period, but increases vulnerability to atrial ﬁbrilla-
tion through increased atrial conduction time, which persisted
following return to eucapnia in an animal model.
9 Increases in
cardiac sympathetic and parasympathetic activity have been
demonstrated to precede the onset of ﬁbrillation in pacing-
induced models of atrial ﬁbrillation.
10 More recent studies
have suggested the importance of both autonomic systems in
rendering the atria at increased risk of ﬁbrillation following
induced apneas.
11,12 Linz has emphasized the particular
importance of negative intrathoracic pressure in promoting
atrial ﬁbrillation through vagal activation, which results in a
marked shortening of the atrial effective refractory period.
12
In these animal models, combined beta-blockade plus atro-
pine,
11 anterior right ganglionic plexus ablation,
11 or renal
sympathetic denervation,
12 but not beta-blockade alone,
prevented the induction of atrial ﬁbrillation. The large changes
in atrial dimension that have been demonstrated during the
Mueller maneuver in humans
13 might also acutely alter atrial
electrophysiology.
Whether it is the acute effects of apneic events or the
chronic structural changes resulting from OSA that predispose
to recurrent atrial ﬁbrillation may have important therapeutic
implications. If it is the former, speciﬁc treatment of OSA with
CPAP, or an alternative therapy that controls OSA, may be
needed to reduce risk of recurrence. This will likely be a
considerable clinical challenge, as only half of patients with
diagnosed OSA in the study by Neilan
1 were adherent to CPAP;
this ﬁgure would likely be even lower if OSA was identiﬁed by
routine screening of patients with atrial ﬁbrillation, because
most OSA cases so identiﬁed do not report excessive
sleepiness.
4 On the other hand, if it is the autonomic effects
of acute apneic events that trigger recurrent atrial ﬁbrillation,
there may be effective alternatives to prevent OSA-related
recurrence for the many patients with comorbid atrial
ﬁbrillation and OSA who are intolerant of CPAP. These may
include pharmacologic modalities, renal sympathetic denerva-
tion, or modiﬁcation of the ablation procedure to include
superior vena cava, as well as pulmonary vein, isolation, as has
been suggested elsewhere for patients with OSA.
14
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